Obesity in the prognosis of women with chronic heart failure
Keywords:
heart failure, obesity, prognosis, female.Abstract
Introduction: Obesity can lead to heart failure through different mechanisms; however, it is a protective factor against mortality for patients diagnosed with the disease.
Objective: To describe the latest findings on obesity in the prognosis of women with chronic heart failure.
Methods: A non-systematic review of 31 documents published in PubMed, Ebsco, Scopus, Cochrane Library, and SciELO was conducted. Heart failure, obesity, prognosis, and female were used as keywords for the search.
Results: In the advanced stage of chronic heart failure, obesity improves the prognosis, since it acts as protective factor against mortality. Sex-dependent differences in such a paradox are described, with better prognosis and lower mortality for females.
Conclusions: Obese women with heart failure have a better long-term prognosis than men with the same disease.
Downloads
References
Pereira-Rodríguez JE, Rincón-González G, Niño-Serrato DR. Insuficiencia cardíaca: Aspectos básicos de una epidemia en aumento. CorSalud, 2016; 8(1):58-70. DOI: https://doi.org/10.1002/ejhf.489
Groenewegen A, Rutten FH, Mosterd A, Hoes A. Epidemiology of heart failure. European Journal of Heart Failure, 2020;22:1342-56. DOI: https://doi.org/10.1002/ejhf.1858
Chao Pereira C. Obesidad y mortalidad en los pacientes con insuficiencia cardíaca crónica. Revista Cubana de Medicina. 2018[acceso 10/04/2021];57(4):a04_405. Disponible en: https://www.revmedicina.sld.cu/index.php/med/article/view/405
Block JP, Subramanian SV, Christakis NA, O’Malley AJ. Population trends and variation in body mass index from 1971 to 2008 in the Framingham heart study offspring cohort. Plos One. 2013;8(5):e63217. DOI: https://doi.org/10.1002/ejhf.489
Dădârlat-Pop A, Sitar-Tăut A, Zdrenghea D, Bogdan C, Raluca T, Dana P, et al. Profile of Obesity and Comorbidities in Elderly Patients with Heart Failure. Clinical Interventions in Aging. 2020;15. DOI: https://doi.org/10.2147/CIA.S248158
Ahmad FS, Hongyan N, Rich JD, Clyde WY, Donald M, John TW. Hypertension, Obesity, Diabetes, and Heart Failure–Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project. JACC Heart Fail. 2016; 4(12): 911-9. DOI: https://doi.org/10.1016/j.jchf.2016.08.001
Horwich TB, Fonarow GC, Hamilton MA. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789-95. PubMed: PMID:11527635. DOI: https://doi.org/10.1002/cphy.c170011.
Alfonzo Guerra JP. Retos de la paradoja mayores riesgos y más expectativa de vida vs realidad en la salud. Rev Cub Med. 2016 [acceso 17/04/2021];55:159-66. Disponible en: https://bvs.sld.cu/revistas/med/vol55_2_16/med07216.htm
Csige I, Ujvárosy D, Szabó Z, István L, György P, Mariann H. The Impact of Obesity on the Cardiovascular System. Journal of Diabetes Research. 2018. DOI: https://doi.org/10.1155/2018/3407306.
Elagizi A, Carbone S, Lavie CJ, Mandeep RM, Hector OV. Implications of obesity across the heart failure continuum. Progress in Cardiovascular Diseases. 2020; YPCAD-01130. DOI: https://doi.org/10.1016/j.pcad.2020.09.005.
Oga EA, Eseyin OR. The Obesity Paradox and Heart Failure: A Systematic Review of a Decade of Evidence. Journal of Obesity. 2016; DOI: https://doi.org/10.1155/2016/9040248
Samson R, Jaiswal A, Ennezat PV, Mark C, Thierry H, Le J. Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2016;5:e002477. DOI: http://doi.org/10.1161/JAHA.115.00247
Hirayama A, Goto T, Shimada YJ, Mohammad KF, Camargo C, Kohei Hasegawa. Association of Obesity With Severity of Heart Failure Exacerbation: A Population-Based Study. J Am Heart Assoc. 2018;7:e008243.DOI: https://doi.org/10.1161/JAHA.117
Ganesh VH, Vasundhara K. Obesity and Cardiometabolic Defects in Heart Failure Pathology. Compr Physiol. 2020;7(4):1463-77. Disponible en: https://doi.org/10.1002/cphy.c170011
Carbone S, Canada JM, Billingsley HE, Mohammad SS Andrew E, Carl JL. Obesity paradox in cardiovascular disease: where do we stand? Vascular Health and Risk Management. 2019;15: 89–100. DOI: https://doi.org/10.2147/VHRM.S168946
Chao Pereira C, Rojas Gutiérrez A, Roselló Azcanio Y, Andre Tiago. Influencia del índice de masa corporal en la mortalidad de pacientes con insuficiencia cardíaca. Rev Cubana Med. 2017 [acceso 01/05/2021];56(3). Disponible en: https://scielo.sld.cu/pdf/med/v56n3/med07317.pdf
Clark AL, Chyub J, Horwich TB. The Obesity Paradox in Men versus Women with Systolic Heart Failure. Am J Cardiol. 2012; 110(1):77–82. DOI: https://doi.org/10.1016/j.amjcard.2012.02.050
: Peterson LR, Soto PF, Herrero P. Impact of gender on the myocardial metabolic response to obesity. J Am Coll Cardiol Img. 2008;1:424–33. DOI: https://doi.org/10.1007/s10741-016-9577-0
Seongkum, Debra K, Susan J, Sandra BD, Kyoung SL, JinShil K, et al. Association Between Obesity and Heart Failure Symptoms in Male and Female Patients. Clin Obes. 2017;7(2):77–85. DOI: https://doi.org/10.1111/cob.12179
Matsushita M, Shirakabe A, Hata N. Association between the body mass index and the clinical findings in patients with acute heart failure: evaluation of the obesity paradox in patients with severely decompensated acute heart failure. 2017;32:600–8. DOI: https://doi.org/10.1007/s00380-01609089
Joyce E, Lala A, Stevens SR, Lauren BC, AbouEzzeddine OF, Groarke JD, et al. Prevalence, Profile and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations. JACC Heart Fail. 2016;4(12):923–31. DOI: https://doi.org/10.1016/j.jchf.2016.09.013
Charnigo R, Guglin M. Obesity paradox in heart failure: statistical artifact, or ímpetus to rethink clinical practice? Heart Fail Rev. 2017;22:13–23. DOI: https://doi.org/10.1007/s10741-016-9577-0
Vest AR, Chan M, Deswal A. Nutrition, obesity, and cachexia in patients with heart failure: A consensus statement from the Heart Failure Society of America scientific statements committee. J Card Fail. 2019;25. DOI: https://doi.org/10.1016/j.cardfail.2019.03.007
Bozkurt B; Shaden Khalaf S. Heart Failure in Women. Methodist debakey cardiovasc J. 2017:13(4) DOI: https://doi.org/10.1136/bmjopen2019036709
Beale A, Cosentino C, Segan L, Justin AM, Donna V, Shona E, et al. The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction. ESC Heart Failure. 2020;(7)77:214–23. DOI: https://doi.org/10.1002/ehf2.12557
Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L. The Heart Failure Overweight/Obesity Survival Paradox: The Missing Sex Link. JACC Heart Fail. 2015;3(11):917-26. DOI: https://doi.org/10.1016/j.jchf.2015.06.009
Araya Marín MG, Romero Polini A. La paradoja de la obesidad en insuficiencia cardíaca. Colecciones medicina, ciencias biomédicas y salud pública. Repositorio Kérwá. 2021 [acceso 10/10/2021]. Disponible en: https://www.kerwa.ucr.ac.cr/handle/10669/84230
Suthahar N, Meems L, Ho J, Rudolf AB. Sex-related differences in contemporary biomarkers for heart failure: a review. European Journal of Heart Failure. 2020; 22: 775–88. DOI: https://doi.org/10.1002/ejhf.1771
Gutiérrez A, Poblador-Plou B, Torres A, Fernando JR, Antonio GM. Sex Differences in Comorbidity, Therapy, and Health Services Use of Heart Failure in Spain: Evidence from Real-World Data. Int. J. Environ. Res. Public Health. 2020;17: 2136. DOI: https://doi.org/10.3390/ijerph17062136
Coutinho T, Goel K, Correa de Sa D, Kragelund C, Kanaya A, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease. A systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. 2011;57:1877-86. DOI: https://doi.org/10.3390/ijjhvph170621368
McCarty MF. A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective. Med Hypotheses. 2003;61:173e6. DOI: https://doi.org/10.3390/ijerph170621368
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Attribution-NonCommercial 4.0 Internacional (CC BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista. o admite fines comerciales. Permite copiar, distribuir e incluir el artículo en un trabajo colectivo (por ejemplo, una antología), siempre y cuando no exista una finalidad comercial, no se altere ni modifique el artículo y se cite apropiadamente el trabajo original. El Comité Editorial se reserva el derecho de introducir modificaciones de estilo y/o acotar los textos que lo precisen, comprometiéndose a respectar el contenido original.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
